InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,564.41
(
1.08%
)
US TECH 100
19,292.80
(
0.00%
)
Dow Jones
40,415.44
(
0.32%
)
Brent Oil
81.73
(
0.26%
)
Bitcoin
66,491.75
(
-1.65%
)
Post# of 131
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

surf1944

Send PM Follow Ignore
Followers 466
Posts 26935
Boards Moderated 2
Alias Born 09/11/2006

surf1944

Re: surf1944 post# 14

Tuesday, 08/14/2012 11:15:28 AM

Tuesday, August 14, 2012 11:15:28 AM

Post# of 131
9:24AM Aegerion Pharma announces date of FDA advisory committee review of Lomitapide NDA (AEGR) 14.19 : Co announced that the FDA has scheduled a meeting of the Endocrinologic and Metabolic Drugs Advisory Committee on October 17, 2012, to review the Company's New Drug Application for lomitapide in the treatment of adult patients with Homozygous Familial Hypercholesterolemia (HoFH). Details of the meeting will be available in the Federal Register.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up